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The role of a biostatistical and epidemiologic review for a clinical journalAnjel Vahratian, PhD
Department of Obstetrics and GynecologyDr Vahratian is the Statistical Consultant for the International Journal
of Gynecology and Obstetrics (IJGO) and an Assistant Professor in the
Department of Obstetrics and Gynecology at the University of Michigan
Medical School, Ann Arbor, USA. She received her bachelor's degree in
statistics and women's studies from the University of Michigan, a master's
degree in public health with a focus on reproductive and perinatal health
from Johns Hopkins University, and a doctoral degree in maternal and child
health epidemiology from theUniversity of North Carolina.During graduate
school, Dr Vahratian completed an internship at the Centers for Disease
Control and Prevention and a fellowship at the National Institutes of Health.
Her research area and publications focus on the health of women prior to
pregnancy and its effect on pregnancy outcomes and maternal postpartum
mental and physical health. In particular, she is interested in the effect of
obesity and diabetes on contraceptive decision-making, pregnancy
planning, andperinatal outcomes. She is committed to developing strategies
to empower women to be proactive about their health during their
childbearing years—pregnancy is a critical period for women and health
during this period can have long-term effects on a woman's quality of life.
Although statistical consultants have a visible presence on the
editorial boards of peer-reviewed obstetrics and gynecology journals,
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doi:10.1016/j.ijgo.2009.07.035their role may be less apparent to a journal's readership. While the
presence of a separate statistical reviewmay be vexing to some authors,
its purpose is to offer the editor and authors constructive feedback on
the quality of the study's design, analysis plan, and findings.
As part of the IJGO's peer review process, the editor will forward a
select number of manuscripts per month to me, as the statistical
consultant, for a biostatistical and epidemiologic review. My evaluation
will provide detailed comments not only on the methods and results
sections, but also on the rationale for the study and the synthesis of the
literature provided. As such, this reviewwill take into consideration not
only how the analysis was executed, but also the logic behind the design
of the analysis. It is ourhope that this approachwill provide authorswith
more concrete feedback, while strengthening the science published in
the Journal.
Each article that undergoes a biostatistical and epidemiologic review
receives a full read-through. In the introduction, we are looking for text
that sets the tone for the rest of the article. It should be brief (approx-
imately one double-spaced page of text) and summarizewhat is known
about the issue and what remains uncertain. A statement that clearly
outlines the purpose of the study should conclude this section.
Themethods section should provide sufficient detail for the reader to
be able to replicate the study on their own. Key components of the
methods section include a brief description of the study design (e.g.
randomized controlled trial; cohort study, prospective or retrospective;
case-control study; cross-sectional study), study population (e.g. inclu-
sion and exclusion criteria, timeline, recruitment strategies), measure-
ment of exposure and outcome, and analysis plan. The analysis plan
should be presented in a logical manner based on: (1) how the analysis
was performed; and (2) how the results are described in the next sec-
tion. For example, descriptive statistics are usually performed first, then
multivariable analyses. Provide the reader with the statistical tests used
to assess statistical significance and the P value used as the cut-point. If a
statistical package (e.g. SPSS, SAS, Stata) was used to perform these
analyses, please include this information in this section.
In the results section, we are looking for an overview of the
sociodemographic characteristics of the study population, followed by
the results of the descriptive andmultivariable analyses performed. The
text should focus on key themes and findings, while corresponding
tables and figures should provide more detail. Tables and figures will be
reviewed for completeness, utility, and ease of interpretation. Tables
should be able to stand on their own, independent of the manuscript;
thus, acronyms are discouraged.
The discussion section is an opportunity to compare your results
with previous studies. It is also a section to acknowledge your study's
strengths and limitations. Rather than reiterating the findings of your
study, this section should provide your findings in context and suggest
areas for future investigation. Your concluding paragraph should focus
on what can be summarized from this analysis. Be careful not to
speculate beyond the scope of the study. For instance, a statisticallytrics. Published by Elsevier Ireland Ltd. All rights reserved.
92 SPECIAL EDITORIALsignificant association does not necessarily imply a causal relationship.
Considerationmust be given to other factors, such as the strength of the
association, consistency in findings, temporality, and biologic plausibil-
ity before such a statement is possible [1].
Overall, we are looking for a cohesive argument from start to finish.
Solidmanuscripts should include: (1) a testable aim in the introduction;
(2) a description of the study, its participants, and the analysis per-
formed; (3) a summary of the results that includes detailed tables
and figures where appropriate; and (4) a discussion that translates the
findings to the broader literature and touches on their clinical andpublic
health significance. In offering both general and specific comments to
the authors as part of the review,we hope that this process provides our
authors with a different perspective on their work and the tools to
strengthen their manuscript upon resubmission.
As our readership is global in nature, we welcome manuscript
submissions from all regions of the world. The translation of basic and
clinical research into clinical practice is dependent not only on the
strength of the evidence but also the generalizability of the study
findings and practicality of the intervention under consideration. The
emergence of evidence-basedmedicine in the early 1990s has sparked a
wealth of information on manuscript preparation [2] and the scientificevaluation of the peer-reviewed literature [3–5] in both print and
electronic media. Authors should peruse these resources, in addition to
the Journal's Instructions for Authors (available online at: www.ees.
elsevier.com/ijg), in advance of their submission to the Journal, to
strengthen their work for publication.References
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